Boomi, a Dell
Technologies business, today announced the launch of the Boomi Molecule AWS
Quick Start. The Boomi Molecule is the first AWS Quick Start(s) that enables an
Integration Platform as a Service (iPaaS) for Amazon Web Services (AWS),
providing customers the ability to configure and run a Boomi Molecule on AWS at
the click of a button implementing specific AWS best practices for security and
high availability.
Customers can drastically reduce the amount of time it takes for them to deploy
a Boomi Molecule into their AWS environment using the Boomi Molecule AWS Quick
Start. The Boomi Molecule AWS Quick Start can reduce hundreds of manual
procedures into just a few steps, so customers can build a Boomi Molecule
production environment quickly and can start using it immediately. The Boomi
Molecule AWS Quick Start includes a reference architecture, as well as a
deployment guide, providing easy to understand instructions on how to deploy a
fully functioning Boomi Molecule cluster on AWS in less than 30 minutes.
Boomi's low code iPaaS is designed to enable easy application and data
integration for AWS customers seeking to connect, migrate, manage, and govern
data across their hybrid, SaaS, and AWS applications, reducing time to
configure and deploy cloud operations. The Boomi Molecule is a single-tenant,
clustered runtime that runs separate from the platform and allows multiple
processes to run concurrently.
"At Boomi, we are constantly working to deliver on our goal for ultimate
customer satisfaction, which is already high, and at the same time seeking to
ensure accelerated business outcomes for our customers," said Steve Wood, Chief
Product Officer at Boomi. "With the Boomi Molecule on AWS Quick Start,
customers can drastically reduce their time to deploy and, as a result, their
time-to-value, while benefiting from the flexibility and scalability of Boomi
products."
For more information about The Boomi Molecule on the AWS Cloud Quick Start,
visit
https://aws.amazon.com/quickstart/architecture/dell-boomi-molecule